MeSH D009181 - mycoses
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001423:Bacterial infections and mycoses
D009181:Â
Mycoses
D000072742:Invasive fungal infections
0 Companies
0 Drugs
Success rate
D001228:Aspergillosis
D002177:Candidiasis
D003047:Coccidioidomycosis
D003453:Cryptococcosis
D003881:Dermatomycoses
0 Companies
0 Drugs
Success rate
D005847:Geotrichosis
0 Companies
0 Drugs
Success rate
D006660:Histoplasmosis
D008172:Fungal lung diseases
0 Companies
0 Drugs
Success rate
D010229:Paracoccidioidomycosis
D010854:Piedra
0 Companies
0 Drugs
Success rate
D016720:Pneumocystis infections
0 Companies
0 Drugs
Success rate
D020096:Zygomycosis
D020314:Central nervous system fungal infections
0 Companies
0 Drugs
Success rate
D060446:Phaeohyphomycosis
0 Companies
0 Drugs
Success rate
D060586:Trichosporonosis
0 Companies
0 Drugs
Success rate
D000092562:Allergic fungal sinusitis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Abbott Biotherapeutics | Amphotericin b | Amphotericin B |  | 1996-12-23 |  |  |
| Able Laboratories | Phenazopyridine, Sulfamethoxazole, Trimethoprim | Sulfamethoxazole Trimethoprim Phenazopyridine |  | 2001-06-26 |  |  |
| Accord Healthcare | Caspofungin | Caspofungin Accord |  | 2016-02-11 |  |  |
| Itraconazole | Itraconazole |  | 2016-05-26 |  |  | |
| Posaconazole | Posaconazole AHCL |  | 2019-07-25 |  |  | |
| Posaconazole | Posaconazole Accord |  | 2019-07-25 |  |  | |
| Voriconazole | Voriconazole Accord |  | 2013-05-16 |  |  | |
| Aet Pharma | Posaconazole | Posaconazole |  | 2021-02-01 |  |  |
| Ajanta Pharma | Voriconazole | Voriconazole |  | 2016-05-24 |  |  |
| Akorn | Nystatin | Nystatin |  | 1994-02-28 |  |  |
| Alembic Pharmaceuticals | Itraconazole | Itraconazole |  | 2016-12-13 |  |  |
| Nystatin, Triamcinolone | Nystatin Triamcinolone |  | 2021-03-31 |  |  | |
| Alkem Laboratories | Itraconazole | Itraconazole |  | 2017-06-12 |  |  |
| Alkopharma USA | Amphotericin b | Amphotec |  | 1996-11-22 |  |  |
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
47%9/19
Phase 2
67%12/18
Phase 3
82%42/51
Approved: 31Overall Success rate: 26%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use